• The Honourable Bill Graham, P.C., M.P., Minister of Foreign Affairs
• The Honourable Lucienne Robillard, P.C., M.P., Minister of Industry

• Christopher Armstrong, Senior Advisor, HIV/AIDS, Human Rights, Humanitarian Affairs and International Women's Equality Division(Foreign Affairs and International Trade Canada)
• Susan Bincoletto, Acting Director General, Marketplace Framework Policy Branch(Industry Canada)
• Sandra Black, Director, Social Development Policies, Policy Branch(Canadian International Development Agency)
• Adrienne Blanchard, Legal Counsel, Gowling, Lafleur and Henderson(Canada's Research-Based Pharmaceutical Companies)
• Doug Clark, Senior Project Leader, Patent Policy Directorate(Industry Canada)
• Éric Dagenais, Director, Patent Policy Directorate(Industry Canada)
• Jim Keon, President(Canadian Generic Pharmaceutical Association)
• David K. Lee, Directorate, Office of Patented Medicines and Liaison, Therapeutic Products Directorate, Health Products and Food Branch(Health Canada)
• Jean-François Leprince, President, Aventis Pharmaceutical, Chair, Rx&D Intellectual Property Committee(Canada's Research-Based Pharmaceutical Companies)
• Terry McCool, Vice-President, Corporate Affairs, Eli Lilly Canada Inc., Vice-Chair, Rx&D Intellectual Property Committee(Canada's Research-Based Pharmaceutical Companies)
• Dr. Robert Peterson, Director General, Therapeutic Products Directorate, Health Products and Food Branch(Health Canada)
• Vishva V. Ramlall, Senior Policy Officer, Corporate Strtegies Branch, Canadian Intellectual Property Office(Industry Canada)
• Rob Sutherland-Brown, Senior Counsel, Industry Canada Legal Services(Industry Canada)

Clause-by-clause consideration